Show simple item record

dc.contributor.authorJiménez-Sánchez, Juan
dc.contributor.authorBosque, Jesús J.
dc.contributor.authorJiménez Londoño, Germán A.
dc.contributor.authorMolina-García, David
dc.contributor.authorMartínez Rubio, Álvaro 
dc.contributor.authorPérez-Beteta, Julián
dc.contributor.authorOrtega-Sabater, Carmen
dc.contributor.authorHonguero Martínez, Antonio F.
dc.contributor.authorGarcía Vicente, Ana M.
dc.contributor.authorCalvo, Gabriel F.
dc.contributor.authorPérez-García, Víctor M.
dc.contributor.otherMatemáticases_ES
dc.date.accessioned2021-03-16T09:55:19Z
dc.date.available2021-03-16T09:55:19Z
dc.date.issued2021-02
dc.identifier.issn0027-8424
dc.identifier.urihttp://hdl.handle.net/10498/24645
dc.description.abstractHuman cancers are biologically and morphologically heterogeneous. A variety of clonal populations emerge within these neoplasms and their interaction leads to complex spatiotemporal dynamics during tumor growth. We studied the reshaping of metabolic activity in human cancers by means of continuous and discrete mathematical models and matched the results to positron emission tomography (PET) imaging data. Our models revealed that the location of increasingly active proliferative cellular spots progressively drifted from the center of the tumor to the periphery, as a result of the competition between gradually more aggressive phenotypes. This computational finding led to the development of a metric, normalized distance from F-18-fluorodeoxyglucose (F-18-FDG) hotspot to centroid (NHOC), based on the separation from the location of the activity (proliferation) hotspot to the tumor centroid. The NHOC metric can be computed for patients using F-18-FDG PET-computed tomography (PET/CT) images where the voxel of maximum uptake (standardized uptake value [SUV]max) is taken as the activity hotspot. Two datasets of F-18-FDG PET/CT images were collected, one from 61 breast cancer patients and another from 161 non-small-cell lung cancer patients. In both cohorts, survival analyses were carried out for the NHOC and for other classical PET/CT-based biomarkers, finding that the former had a high prognostic value, outperforming the latter. In summary, our work offers additional insights into the evolutionary mechanisms behind tumor progression, provides a different PET/CT-based biomarker, and reveals that an activity hotspot closer to the tumor periphery is associated to a worst patient outcome.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherNATL ACAD SCIENCESes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePNAS February 9, 2021 118 (6) e2018110118es_ES
dc.subjectcanceres_ES
dc.subjectF-18-FDG PET/CTes_ES
dc.subjectevolutionary dynamicses_ES
dc.subjectprognostic biomarkeres_ES
dc.titleEvolutionary dynamics at the tumor edge reveal metabolic imaging biomarkerses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1073/pnas.2018110118


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional